| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1800048 | 重组抗肿瘤坏死因子-α（TNF-α）全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2018-04-28 | 山东丹红制药有限公司 | Shandong Danhong Pharmaceutical Co Ltd | Certificate Issued | 2018-10-08 | view |